Literature DB >> 11166279

Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.

K Teichert-Kuliszewska1, P C Maisonpierre, N Jones, A I Campbell, Z Master, M P Bendeck, K Alitalo, D J Dumont, G D Yancopoulos, D J Stewart.   

Abstract

The endothelial cell (EC) specific tyrosine kinase receptor, Tie2, interacts with at least two ligands, angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2). Ang1 stimulates Tie2 receptor autophosphorylation, while Ang2 has been reported to inhibit Ang1-induced Tie2 receptor autophosphorylation. We studied the effects of Ang1 and Ang2 in an in vitro model of angiogenesis. Human ECs (HUVEC), cultured on 3-D fibrin matrices, were treated with conditioned media (CM) from stably transfected cells expressing human Ang1 or Ang2, or with purified recombinant proteins. EC tube formation was measured as a differentiation index (DI), calculated as the ratio of total tube length over residual of EC monolayer. CM from Ang1 overexpressing A10 SMC or HEK293T cells induced profound HUVEC differentiation, resulting in the formation of extensive capillary-like tubes within 48 h (DI: 24.58+/-5.91 and 19.13+/-7.86, respectively) vs. control (DI: 2.73+/-1.68 and 2.15+/-1.45, respectively, both P<0.001). Interestingly, CM from two independent cell lines overexpressing Ang2 also produced a significant increase in EC differentiation (DI: 9.22+/-3.00 and 9.72+/-4.84, both P<0.005 vs. control) although the degree of angiogenesis was significantly less then that seen with Ang1. Addition of Ang1* (a genetically engineered variant of naturally occurring Ang1) or Ang2 also resulted in dose dependent increases in DI, which were blocked by an excess of soluble Tie2 receptor (20 microg/ml). Both Ang1* and Ang2 induced modest increases in [3H]thymidine incorporation into HUVECs (20 and 26%, respectively), which were inhibited by excess soluble Tie2. Although Ang2 was unable to induce significant Tie2 receptor phosphorylation during a 5-min exposure, a 24-h pretreatment with Ang2, followed by brief re-exposure, produced Tie2 phosphorylation in HUVEC comparable to that produced by Ang1*. These results demonstrate for the first time that Ang2 may have a direct role in stimulating Tie2 receptor signaling and inducing in vitro angiogenesis. Our findings suggest that the physiological role of Ang2 is more complex than previously recognized: acting alternately to promote or blunt Tie2 receptor signaling in endothelial cells, depending on local conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166279     DOI: 10.1016/s0008-6363(00)00231-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  87 in total

1.  Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function.

Authors:  Kevin P Claffey
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 2.  The impact of anti-angiogenic agents on cancer therapy.

Authors:  Dieter Marmé
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-16       Impact factor: 4.553

Review 3.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

4.  Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma.

Authors:  Saritha Sandra D'Souza; Karine Scherzinger-Laude; Marc Simon; Bharathi P Salimath; Jochen Rössler
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-10       Impact factor: 4.553

Review 5.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

6.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

7.  A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

Authors:  Daniel Voskas; Nina Jones; Paul Van Slyke; Celina Sturk; Wing Chang; Alex Haninec; Yael Olya Babichev; Jennifer Tran; Zubin Master; Stephen Chen; Nicole Ward; Maribelle Cruz; Jamie Jones; Robert S Kerbel; Serge Jothy; Lina Dagnino; Jack Arbiser; Giannoula Klement; Daniel J Dumont
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice.

Authors:  Jolanta E Pitera; Adrian S Woolf; Nicholas W Gale; George D Yancopoulos; Hai Tao Yuan
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  VE-statin, an endothelial repressor of smooth muscle cell migration.

Authors:  Fabrice Soncin; Virginie Mattot; Frédéric Lionneton; Nathalie Spruyt; Frédéric Lepretre; Agnès Begue; Dominique Stehelin
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  Colorectal resection, both open and laparoscopic-assisted, in patients with benign indications is associated with proangiogenic changes in plasma angiopoietin 1 and 2 levels.

Authors:  H M C Shantha Kumara; A Hoffman; I Y Kim; D Feingold; N Dujovny; M Kalady; M Kallady; M Luchtefeld; R L Whelan
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.